Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioEngine Sci-Tech is a leading Chinese biotechnology company specializing in the development and manufacturing of high-performance serum-free cell culture media. The company provides comprehensive solutions for the biopharmaceutical industry, including customized media formulation, process optimization, and CDMO services for vaccines, monoclonal antibodies, and cell and gene therapies. Founded by experts from East China University of Science and Technology, BioEngine leverages a proprietary metabolomics-driven platform to design media that maximizes cell growth and product yield. The company operates large-scale GMP-compliant manufacturing facilities for both liquid and dry powder media to ensure supply chain security for global biologics producers. BioEngine is recognized as a key player in the localization of critical raw materials within the bioprocessing sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioEngine Sci-Tech.